Summary
The liver inhibitory factor (LIF) extracted inhibits in vitro the proliferation of erythroleukemic cells. This inhibition takes place 24 h after LIF treatment and is promptly reversible on removal of the factor.3H-thymidine autoradiography shows that the effect is probably due to a blockage of the cells at the end of G1.
References
Higueret, P., Chany, E., Mousset, S., Gardes, M., and Frayssinet, C., C. r. Acad. Sci. Paris281 (1975) 49.
Chany, E., and Frayssinet, C., C. r. Acad. Sci. Paris272 (1971) 2644.
Pietu, G., Munsch, N., Mousset, S., and Frayssinet, C., Cell Tissue Kinet.12 (1979) 153.
Lewensohn, R., and Ringborg, U., Blood55 (1980) 311.
Viola-Magni, M. P., and Serenelli, G., Atti Congr. Soc. it biol. sper., Caserta No. 120 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Viola-Magni, M.P., Ricerchi, P. Inhibition of DNA synthesis in erythroleukemic cells by a liver protein fraction. Experientia 39, 180–182 (1983). https://doi.org/10.1007/BF01958888
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01958888